uno q1 ionic exchange chromatography column Search Results


bio rad uno q1 anion exchange fplc column  (Bio-Rad)
99
Bio-Rad bio rad uno q1 anion exchange fplc column
Bio Rad Uno Q1 Anion Exchange Fplc Column, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/UNO+Q1+Column/pmc01133744-181-7-7
Average 99 stars, based on 1 article reviews
bio rad uno q1 anion exchange fplc column - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
gene exp ndufv1 mm00504941 m1  (Thermo Fisher)
85
Thermo Fisher gene exp ndufv1 mm00504941 m1
Gene Exp Ndufv1 Mm00504941 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/Gene+Exp%2E+Ndufv1%2C+Mm00504941_m1/pm31204316-365-71--1
Average 85 stars, based on 1 article reviews
gene exp ndufv1 mm00504941 m1 - by Bioz Stars, 2026-09
85/100 stars
  Buy from Supplier
n n dimethyl formamide dmf  (Chem Impex International)
95
Chem Impex International n n dimethyl formamide dmf
N N Dimethyl Formamide Dmf, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/Methanol/pm31577142__ja9b09067_si_001-20-0-51
Average 95 stars, based on 1 article reviews
n n dimethyl formamide dmf - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
anion exchange chromatography  (Cytiva Europe)
96
Cytiva Europe anion exchange chromatography
Anion Exchange Chromatography, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/RESOURCE+Q/pm25633630-136-5-16
Average 96 stars, based on 1 article reviews
anion exchange chromatography - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
275 q2  (Bio-Rad)
93
Bio-Rad 275 q2

275 Q2, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/Lyphochek+Whole+Blood+Immunosuppressant+Control/pmc10641704-180-151-126
Average 93 stars, based on 1 article reviews
275 q2 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
q1 ave q2 ave q3 ave q4 ave cst  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc q1 ave q2 ave q3 ave q4 ave cst

Q1 Ave Q2 Ave Q3 Ave Q4 Ave Cst, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/Phospho-Histone+H2A%2EX+(Ser139)+Mouse+mAb/10__1016_slash_j__jece__2019__102943-189-12-20
Average 96 stars, based on 1 article reviews
q1 ave q2 ave q3 ave q4 ave cst - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
nadh dehydrogenase ubiquinone 1 beta subcomplex 8  (Proteintech)
95
Proteintech nadh dehydrogenase ubiquinone 1 beta subcomplex 8

Nadh Dehydrogenase Ubiquinone 1 Beta Subcomplex 8, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/NDUFB8+Antibody/pmc12699140-113-72-84
Average 95 stars, based on 1 article reviews
nadh dehydrogenase ubiquinone 1 beta subcomplex 8 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
api 3200 lc/ms/ms  (MDS Inc)
90
MDS Inc api 3200 lc/ms/ms
General scan map by <t>LC-MS/MS.</t>
Api 3200 Lc/Ms/Ms, supplied by MDS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/api+3200+lc+ms+ms/pmc05457892-36-6-12
Average 90 stars, based on 1 article reviews
api 3200 lc/ms/ms - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
anion exchange chromatography  (Bio-Rad)
94
Bio-Rad anion exchange chromatography
General scan map by <t>LC-MS/MS.</t>
Anion Exchange Chromatography, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/Protein+Standard+for+Anion+Exchange+Chromatography/pm22191421-37-25-28
Average 94 stars, based on 1 article reviews
anion exchange chromatography - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
nadh ubiquinone oxidoreductase nd1  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology nadh ubiquinone oxidoreductase nd1
General scan map by <t>LC-MS/MS.</t>
Nadh Ubiquinone Oxidoreductase Nd1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/ND1+Antibody/pm29159335-35-22-54
Average 93 stars, based on 1 article reviews
nadh ubiquinone oxidoreductase nd1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
gene exp ndufa2 mm00477755 g1  (Thermo Fisher)
86
Thermo Fisher gene exp ndufa2 mm00477755 g1
General scan map by <t>LC-MS/MS.</t>
Gene Exp Ndufa2 Mm00477755 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uno+q1+ionic+exchange+chromatography+column/Gene+Exp%2E+Ndufa2%2C+Mm00477755_g1/pm23329824-82-94-11
Average 86 stars, based on 1 article reviews
gene exp ndufa2 mm00477755 g1 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Journal: EFSA Journal

Article Title: Scientific opinion on the tolerable upper intake level for folate

doi: 10.2903/j.efsa.2023.8353

Figure Lengend Snippet:

Article Snippet: Martínez et al. ( ) WBF US RCT analysed as PC 3 yrs Mixed , N = 1429 Population sampled: 40–80 yrs who had had ≥1 colorectal adenoma measuring ≥3 mm removed at colonoscopy within 3 months before study entry were recruited Exclusion criteria: subjects with a personal history of inflammatory bowel disease or hereditary colon cancer syndromes as well as those with more than one first‐degree family member with CRC % lost to follow‐up: 8.8% N = 1014 Sex (% women): 30% Age (mean ± SD): 65,275 ± 8.95 , Data on adenoma characteristics (i.e. number, size, location, histology) were obtained from medical records and pathology reports as previously reported FFQ was used for the dietary intake and plasma folate was analysed by using the Bio‐Rad Quantaphase II Radioassay , Unit of measurement Plasma folate (nmol/L) Q1: <5.02 Q2: 5.02–8.19 Q3: 8.20–12.75 Q4: >12.75 Total folate intake (μg/d), mean: Q1: <275 Q2: 275–414 Q3: 415–664 Q4: >664 Energy‐adjusted: no , Incident recurrence/ without recurrence Q1: 133/254 Q2: 115/254 Q3: 128/253 Q4: 119/253 Dietary folate: Q1: 121/254 Q2: 129/253 Q3: 124/254 Q4: 121/253 Total folate intake: Q1: 137/254 Q2: 126/253 Q3: 119/254 Q4: 113/253 , Adjusted for age, sex, number of colonoscopies, history of polyps before baseline examination. , OR (95% CI) Plasma folate vs. adenoma recurrence Q1 (ref): 1.00 Q2: 0.61 (0.42, 0.89) Q3: 0.79 (0.54, 1.15) Q4: 0.66 (0.46, 0.97) p for trend: 0.04 Total folate intake vs. adenoma recurrence Q1 (ref): 1.00 Q2: 0.75 (0.52, 1.09) Q3: 0.71 (0.48, 1.03) Q4: 0.61 (0.42, 0.89) p for trend: 0.01.

Techniques: Biomarker Discovery, Clinical Proteomics, Microbial Assay, Activity Assay, In Situ, Modification, Chemiluminescence Immunoassay, Control, Northern Blot, Histopathology, RIA Assay, Sampling, Chromatography, Mass Spectrometry, Concentration Assay, Diagnostic Assay, Derivative Assay, Liquid Chromatography

Journal: EFSA Journal

Article Title: Scientific opinion on the tolerable upper intake level for folate

doi: 10.2903/j.efsa.2023.8353

Figure Lengend Snippet:

Article Snippet: Martínez et al. ( ) WBF US RCT analysed as PC 3 yrs Mixed , N = 1429 Population sampled: 40–80 yrs who had had ≥1 colorectal adenoma measuring ≥3 mm removed at colonoscopy within 3 months before study entry were recruited Exclusion criteria: subjects with a personal history of inflammatory bowel disease or hereditary colon cancer syndromes as well as those with more than one first‐degree family member with CRC % lost to follow‐up: 8.8% N = 1014 Sex (% women): 30% Age (mean ± SD): 65,275 ± 8.95 , Data on adenoma characteristics (i.e. number, size, location, histology) were obtained from medical records and pathology reports as previously reported FFQ was used for the dietary intake and plasma folate was analysed by using the Bio‐Rad Quantaphase II Radioassay , Unit of measurement Plasma folate (nmol/L) Q1: <5.02 Q2: 5.02–8.19 Q3: 8.20–12.75 Q4: >12.75 Total folate intake (μg/d), mean: Q1: <275 Q2: 275–414 Q3: 415–664 Q4: >664 Energy‐adjusted: no , Incident recurrence/ without recurrence Q1: 133/254 Q2: 115/254 Q3: 128/253 Q4: 119/253 Dietary folate: Q1: 121/254 Q2: 129/253 Q3: 124/254 Q4: 121/253 Total folate intake: Q1: 137/254 Q2: 126/253 Q3: 119/254 Q4: 113/253 , Adjusted for age, sex, number of colonoscopies, history of polyps before baseline examination. , OR (95% CI) Plasma folate vs. adenoma recurrence Q1 (ref): 1.00 Q2: 0.61 (0.42, 0.89) Q3: 0.79 (0.54, 1.15) Q4: 0.66 (0.46, 0.97) p for trend: 0.04 Total folate intake vs. adenoma recurrence Q1 (ref): 1.00 Q2: 0.75 (0.52, 1.09) Q3: 0.71 (0.48, 1.03) Q4: 0.61 (0.42, 0.89) p for trend: 0.01.

Techniques: Clinical Proteomics

Journal: EFSA Journal

Article Title: Scientific opinion on the tolerable upper intake level for folate

doi: 10.2903/j.efsa.2023.8353

Figure Lengend Snippet:

Article Snippet: Martínez et al. ( ) WBF US RCT analysed as PC 3 yrs Mixed , N = 1429 Population sampled: 40–80 yrs who had had ≥1 colorectal adenoma measuring ≥3 mm removed at colonoscopy within 3 months before study entry were recruited Exclusion criteria: subjects with a personal history of inflammatory bowel disease or hereditary colon cancer syndromes as well as those with more than one first‐degree family member with CRC % lost to follow‐up: 8.8% N = 1014 Sex (% women): 30% Age (mean ± SD): 65,275 ± 8.95 , Data on adenoma characteristics (i.e. number, size, location, histology) were obtained from medical records and pathology reports as previously reported FFQ was used for the dietary intake and plasma folate was analysed by using the Bio‐Rad Quantaphase II Radioassay , Unit of measurement Plasma folate (nmol/L) Q1: <5.02 Q2: 5.02–8.19 Q3: 8.20–12.75 Q4: >12.75 Total folate intake (μg/d), mean: Q1: <275 Q2: 275–414 Q3: 415–664 Q4: >664 Energy‐adjusted: no , Incident recurrence/ without recurrence Q1: 133/254 Q2: 115/254 Q3: 128/253 Q4: 119/253 Dietary folate: Q1: 121/254 Q2: 129/253 Q3: 124/254 Q4: 121/253 Total folate intake: Q1: 137/254 Q2: 126/253 Q3: 119/254 Q4: 113/253 , Adjusted for age, sex, number of colonoscopies, history of polyps before baseline examination. , OR (95% CI) Plasma folate vs. adenoma recurrence Q1 (ref): 1.00 Q2: 0.61 (0.42, 0.89) Q3: 0.79 (0.54, 1.15) Q4: 0.66 (0.46, 0.97) p for trend: 0.04 Total folate intake vs. adenoma recurrence Q1 (ref): 1.00 Q2: 0.75 (0.52, 1.09) Q3: 0.71 (0.48, 1.03) Q4: 0.61 (0.42, 0.89) p for trend: 0.01.

Techniques: Concentration Assay, Microbial Assay, Activity Assay, Selection, Clinical Proteomics, Biomarker Discovery, Western Blot, Sampling

General scan map by LC-MS/MS.

Journal: Medicine

Article Title: Biomarkers of unstable angina pectoris and yangxin decoction intervention

doi: 10.1097/MD.0000000000006998

Figure Lengend Snippet: General scan map by LC-MS/MS.

Article Snippet: Serum samples were analyzed using an LC-MS/MS 3200 Q1 (API 3200 LC/MS/MS, MDS Inc., Ontario, Canada) full scan test with flow phase B (10 mmol/L, ammonium acetate, and 0.10% formic acid) and flow phase C (acetonitrile column: Eclip XDB C18 (Agilent Technologies, Inc. Santa Clara), 46 × 150 mm, 5 μm), with an Aglient sample (Agilent Technologies, Inc. Santa Clara) volume of 5 μL, and the following mass spectrometry parameters: Curtain Gas (CUR), 25.00; temperature (TEM), 550.00; Ion Source Gas (GS1), 50.00; GS2, 60.00; ihe turn on (ON); IS, −4500.00; declustering potential (DP), −50.00; and EP, −10.00.

Techniques: Liquid Chromatography with Mass Spectroscopy

Scan map by LC-MS/MS in UA patients.

Journal: Medicine

Article Title: Biomarkers of unstable angina pectoris and yangxin decoction intervention

doi: 10.1097/MD.0000000000006998

Figure Lengend Snippet: Scan map by LC-MS/MS in UA patients.

Article Snippet: Serum samples were analyzed using an LC-MS/MS 3200 Q1 (API 3200 LC/MS/MS, MDS Inc., Ontario, Canada) full scan test with flow phase B (10 mmol/L, ammonium acetate, and 0.10% formic acid) and flow phase C (acetonitrile column: Eclip XDB C18 (Agilent Technologies, Inc. Santa Clara), 46 × 150 mm, 5 μm), with an Aglient sample (Agilent Technologies, Inc. Santa Clara) volume of 5 μL, and the following mass spectrometry parameters: Curtain Gas (CUR), 25.00; temperature (TEM), 550.00; Ion Source Gas (GS1), 50.00; GS2, 60.00; ihe turn on (ON); IS, −4500.00; declustering potential (DP), −50.00; and EP, −10.00.

Techniques: Liquid Chromatography with Mass Spectroscopy

Two-dimensional maps of LC-MS/MS in UA patients.

Journal: Medicine

Article Title: Biomarkers of unstable angina pectoris and yangxin decoction intervention

doi: 10.1097/MD.0000000000006998

Figure Lengend Snippet: Two-dimensional maps of LC-MS/MS in UA patients.

Article Snippet: Serum samples were analyzed using an LC-MS/MS 3200 Q1 (API 3200 LC/MS/MS, MDS Inc., Ontario, Canada) full scan test with flow phase B (10 mmol/L, ammonium acetate, and 0.10% formic acid) and flow phase C (acetonitrile column: Eclip XDB C18 (Agilent Technologies, Inc. Santa Clara), 46 × 150 mm, 5 μm), with an Aglient sample (Agilent Technologies, Inc. Santa Clara) volume of 5 μL, and the following mass spectrometry parameters: Curtain Gas (CUR), 25.00; temperature (TEM), 550.00; Ion Source Gas (GS1), 50.00; GS2, 60.00; ihe turn on (ON); IS, −4500.00; declustering potential (DP), −50.00; and EP, −10.00.

Techniques: Liquid Chromatography with Mass Spectroscopy

Three-dimensional maps of LC-MS/MS in UA patients.

Journal: Medicine

Article Title: Biomarkers of unstable angina pectoris and yangxin decoction intervention

doi: 10.1097/MD.0000000000006998

Figure Lengend Snippet: Three-dimensional maps of LC-MS/MS in UA patients.

Article Snippet: Serum samples were analyzed using an LC-MS/MS 3200 Q1 (API 3200 LC/MS/MS, MDS Inc., Ontario, Canada) full scan test with flow phase B (10 mmol/L, ammonium acetate, and 0.10% formic acid) and flow phase C (acetonitrile column: Eclip XDB C18 (Agilent Technologies, Inc. Santa Clara), 46 × 150 mm, 5 μm), with an Aglient sample (Agilent Technologies, Inc. Santa Clara) volume of 5 μL, and the following mass spectrometry parameters: Curtain Gas (CUR), 25.00; temperature (TEM), 550.00; Ion Source Gas (GS1), 50.00; GS2, 60.00; ihe turn on (ON); IS, −4500.00; declustering potential (DP), −50.00; and EP, −10.00.

Techniques: Liquid Chromatography with Mass Spectroscopy